World Economic Forum December 5, 2019
Dr Nina Rawal Founder and Managing Director, Emerging Health Ventures

A venture capital model could bring new treatment options to patients in low and middle-income countriesent in LMIC
  • Venture capital can turn scientific discoveries into products for patients in low and middle income countries.
  • It has transformed the market for rare disease medicines, bringing huge benefit to patients worldwide.
  • Healthcare innovation in low-income countries driven by a venture capital model could also benefit high-income countries, which share the same disease challenges.

Important gains have been made in global health in the past few decades: the rate of deaths caused by malaria has halved, HIV/AIDS is no longer a death sentence and the same might soon be true for Ebola judging by the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Insurance, Investments, Medical Devices, Patient / Consumer, Pharma, Provider, Technology, Trends
‘Investors Are Hungry To Find the Best’: It’s Feast or Famine in Digital Behavioral Health Investing
Avive scores $57M for portable cardiac arrest device
Value-based care strategy company Lumeris secures $100M
With $75m cash injection, SynOx plans ph3 rare tumour trial
Hippocratic AI Raises $53 Million Series A at a $500 Million Valuation

Share This Article